CA2577258C - Hexadecasaccharides biotinyles, leur preparation et leur utilisation comme anticoagulants et antithrombotique de l'heparine - Google Patents

Hexadecasaccharides biotinyles, leur preparation et leur utilisation comme anticoagulants et antithrombotique de l'heparine Download PDF

Info

Publication number
CA2577258C
CA2577258C CA2577258A CA2577258A CA2577258C CA 2577258 C CA2577258 C CA 2577258C CA 2577258 A CA2577258 A CA 2577258A CA 2577258 A CA2577258 A CA 2577258A CA 2577258 C CA2577258 C CA 2577258C
Authority
CA
Canada
Prior art keywords
glucopyranosyl
methyl
tri
fwdarw
sulfonato
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2577258A
Other languages
English (en)
French (fr)
Other versions
CA2577258A1 (fr
Inventor
Philippe Duchaussoy
Jean Pascal Herault
Jean Marc Herbert
Maurice Petitou
Pierre Savi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Aventis France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34948342&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2577258(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Aventis France filed Critical Sanofi Aventis France
Publication of CA2577258A1 publication Critical patent/CA2577258A1/fr
Application granted granted Critical
Publication of CA2577258C publication Critical patent/CA2577258C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/10—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Vascular Medicine (AREA)
  • Biochemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Transplantation (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Materials For Medical Uses (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
CA2577258A 2004-09-09 2005-09-07 Hexadecasaccharides biotinyles, leur preparation et leur utilisation comme anticoagulants et antithrombotique de l'heparine Expired - Fee Related CA2577258C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0409557A FR2874924B1 (fr) 2004-09-09 2004-09-09 Hexadecasaccharides biotinyles, leur preparation et leur utilisation therapeutique
FR0409557 2004-09-09
PCT/FR2005/002218 WO2006030104A1 (fr) 2004-09-09 2005-09-07 Hexadecasaccharides biotinyles, leur preparation et leur utilisation

Publications (2)

Publication Number Publication Date
CA2577258A1 CA2577258A1 (fr) 2006-03-23
CA2577258C true CA2577258C (fr) 2013-05-21

Family

ID=34948342

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2577258A Expired - Fee Related CA2577258C (fr) 2004-09-09 2005-09-07 Hexadecasaccharides biotinyles, leur preparation et leur utilisation comme anticoagulants et antithrombotique de l'heparine

Country Status (38)

Country Link
US (3) US20070270342A1 (https=)
EP (1) EP1791872B1 (https=)
JP (1) JP5108519B2 (https=)
KR (1) KR101223364B1 (https=)
CN (1) CN101039963B (https=)
AR (1) AR051286A1 (https=)
AT (1) ATE420118T1 (https=)
AU (1) AU2005284080B2 (https=)
BR (1) BRPI0515078A (https=)
CA (1) CA2577258C (https=)
CY (1) CY1109126T1 (https=)
DE (1) DE602005012287D1 (https=)
DK (1) DK1791872T3 (https=)
EA (1) EA012587B1 (https=)
EC (1) ECSP077272A (https=)
ES (1) ES2320576T3 (https=)
FR (1) FR2874924B1 (https=)
GT (1) GT200500250A (https=)
HN (1) HN2005000518A (https=)
HR (1) HRP20090180T1 (https=)
IL (1) IL181569A (https=)
MA (1) MA28859B1 (https=)
MX (1) MX2007002875A (https=)
MY (1) MY140666A (https=)
NI (1) NI200700063A (https=)
NO (1) NO20071754L (https=)
PA (1) PA8644201A1 (https=)
PE (1) PE20060663A1 (https=)
PL (1) PL1791872T3 (https=)
PT (1) PT1791872E (https=)
RS (1) RS50762B (https=)
SI (1) SI1791872T1 (https=)
SV (1) SV2006002221A (https=)
TN (1) TNSN07053A1 (https=)
TW (1) TW200612970A (https=)
UY (1) UY29102A1 (https=)
WO (1) WO2006030104A1 (https=)
ZA (1) ZA200702255B (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2912409B1 (fr) * 2007-02-14 2012-08-24 Sanofi Aventis Heparines de bas poids moleculaire comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine leur procede de preparation,leur utilisation
FR2912408A1 (fr) * 2007-02-14 2008-08-15 Sanofi Aventis Sa Heparine comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine,leur procede de preparation,leur utilisation
TW201006479A (en) * 2008-07-18 2010-02-16 Sanofi Aventis Use of idrabiotaparinux for decreasing the incidence of bleedings during an antithrombotic treatment
EP2145624A1 (en) * 2008-07-18 2010-01-20 Sanofi-Aventis Use of idrabiotaparinux for decreasing the incidence of bleedings during an antithrombotic treatment
EP2233143A1 (en) * 2009-03-24 2010-09-29 Sanofi-Aventis Use of idrabiotaparinux for decreasing the incidence of bleedings during an antithrombotic treatment
FR2935387B1 (fr) * 2008-08-26 2010-09-10 Sanofi Aventis Hexadecasaccharides a activite antithrombotique comprenant une liaison covalente avec une chaine amine
FR2952935B1 (fr) 2009-11-20 2011-12-02 Sanofi Aventis Procede de preparation du n-biotinyl-6-aminocaproate de n succinimidyle

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU563351C (en) 1982-01-15 2003-06-19 Glaxo Group Limited Synthesis of oligosaccharides
EP0300099A1 (en) 1987-07-20 1989-01-25 Akzo N.V. New pentasaccharides
IL102758A (en) 1991-08-23 1997-03-18 Akzo Nv Glycosaminoglycanoid derivatives, their preparation and pharmaceutical compositions comprising them
FR2704226B1 (fr) 1993-04-22 1995-07-21 Sanofi Elf 3-desoxy oligosaccharides, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
NZ264340A (en) 1993-09-01 1995-04-27 Akzo Nobel Nv Bisconjugate comprising two saccharides and a spacer, use in pharmaceutical compositions
FR2751334B1 (fr) 1996-07-19 1998-10-16 Sanofi Sa Polysaccharides synthetiques, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2773801B1 (fr) 1998-01-19 2000-05-12 Sanofi Sa Nouveaux pentasaccharides, procedes pour leurs preparations et compositions pharmaceutiques les contenant
FR2773804B1 (fr) 1998-01-19 2000-02-18 Sanofi Sa Polysaccharides de synthese, procede pour leur preparation et compositions pharmaceutiques le contenant
FR2814463B1 (fr) * 2000-09-22 2002-11-15 Sanofi Synthelabo Nouveaux polysaccharides a activite antithrombotique comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine

Also Published As

Publication number Publication date
IL181569A0 (en) 2007-07-04
ECSP077272A (es) 2007-03-29
IL181569A (en) 2011-08-31
HRP20090180T1 (en) 2009-05-31
PL1791872T3 (pl) 2009-06-30
CY1109126T1 (el) 2014-07-02
CA2577258A1 (fr) 2006-03-23
ZA200702255B (en) 2008-09-25
US20100279960A1 (en) 2010-11-04
GT200500250A (es) 2006-04-10
US20130004551A1 (en) 2013-01-03
EA012587B1 (ru) 2009-10-30
AR051286A1 (es) 2007-01-03
HN2005000518A (es) 2009-06-01
US20070270342A1 (en) 2007-11-22
RS50762B (sr) 2010-08-31
EP1791872A1 (fr) 2007-06-06
PE20060663A1 (es) 2006-08-21
MY140666A (en) 2010-01-15
JP5108519B2 (ja) 2012-12-26
TNSN07053A1 (fr) 2008-06-02
MA28859B1 (fr) 2007-09-03
MX2007002875A (es) 2007-05-16
AU2005284080A1 (en) 2006-03-23
NI200700063A (es) 2008-03-07
SI1791872T1 (sl) 2009-06-30
AU2005284080B2 (en) 2011-10-13
TW200612970A (en) 2006-05-01
PA8644201A1 (es) 2006-05-16
ES2320576T3 (es) 2009-05-25
FR2874924B1 (fr) 2006-12-01
HK1113686A1 (en) 2008-10-10
DE602005012287D1 (de) 2009-02-26
FR2874924A1 (fr) 2006-03-10
CN101039963B (zh) 2011-07-27
EA200700594A1 (ru) 2007-08-31
JP2008512538A (ja) 2008-04-24
KR20070051887A (ko) 2007-05-18
BRPI0515078A (pt) 2008-07-01
SV2006002221A (es) 2006-01-13
CN101039963A (zh) 2007-09-19
NO20071754L (no) 2007-04-02
UY29102A1 (es) 2006-04-28
WO2006030104A1 (fr) 2006-03-23
PT1791872E (pt) 2009-03-27
DK1791872T3 (da) 2009-05-04
EP1791872B1 (fr) 2009-01-07
US8557968B2 (en) 2013-10-15
KR101223364B1 (ko) 2013-01-16
ATE420118T1 (de) 2009-01-15
US8703738B2 (en) 2014-04-22

Similar Documents

Publication Publication Date Title
EP1322673B1 (fr) Polysaccharides a activite antithrombotique comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine
EP0912613A1 (fr) Polysaccharides synthetiques, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2935386A1 (fr) Nouveaux polysaccharides a activite antithrombotique comprenant une liaion covalente avec une chaine amine
US8703738B2 (en) Biotinylated hexadecasaccharides, preparation and use thereof
FR2773804A1 (fr) Polysaccharides de synthese, procede pour leur preparation et compositions pharmaceutiques le contenant
CA2771056C (fr) Octasaccharides n-acyles activateurs des recepteurs des fgfs, leur preparation et leur application en therapeutique
CA2771055C (fr) Oligosaccharides n-sulfates activateurs des recepteurs des fgfs, leur preparation et leur application en therapeutique
CN103443114A (zh) 激活fgf受体的3-o-烷基寡糖、其制备及其治疗用途
FR2935387A1 (fr) Hexadecasaccharides a activite antithrombotique comprenant une liaison covalente avec une chaine amine
HK1113686B (en) Biotinylated hexadecasaccharides, preparation and use thereof
FR2964660A1 (fr) Nouveaux polysaccharides biotinyles a activite antithrombotique et presentant une stabilite metabolique amelioree
EP2614089A1 (fr) Polysaccharides biotinyles a activite antithrombotique et presentant une stabilite metabolique amelioree
HK1053316B (en) Polysaccharides with antithrombotic activity comprising at least a covalent bond with biotin or a biotin derivative

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20180907